Follow-up of participants enrolled in the primavera-escuddo trial
Ended Awarded Last action
- Contract number
- 75N91019F00130
- Awardee
-
Fundacion Inciensa UEI KDL2VERNRKA5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $869,287
Award facts
- Contract value 100% obligated
- $869,287.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541720 Research and Development in the Social Sciences and Humanities
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Sealed Bid
- Pricing
- Firm Fixed Price
- Place of performance
- Costa Rica
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $238,965 | |
| Exercise an Option | $295,832 | |
| Change Order | $261,393 | |
| Original award | $73,097 |
About this award
This firm fixed price delivery order contract was awarded by the Department of Health and Human Services' National Institutes of Health and National Cancer Institute to Fundacion Inciensa, an international non-profit organization and foundation. The $869,287 contract supports the follow-up of participants enrolled in the PRIMAVERA-ESCUDDO clinical trial, which is evaluating the single dose protection afforded by prophylactic human papillomavirus (HPV) vaccines. The work will be performed in Costa Rica over a period ending on September 15, 2023. Fundacion Inciensa has previously received other prime federal contracts from these agencies ranging from $700,447 to $6.9 million for HPV and COVID-19 related research and services, including clinical trials, data collection, laboratory testing, and investigations into disease transmission and vaccine efficacy. No set-aside designation was used for this award.
Quick answers
Who was awarded contract 75N91019F00130?
75N91019F00130 was awarded to Fundacion Inciensa by National Cancer Institute (National Institutes of Health) on September 16, 2019.
How much is contract 75N91019F00130 worth?
The government has obligated $869,287 on 75N91019F00130.
Is contract 75N91019F00130 an order under another contract?
Yes. 75N91019F00130 is a delivery order under HHSN261201700012I, an indefinite delivery contract.
Was contract 75N91019F00130 competed?
The extent of competition for 75N91019F00130 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award